Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3033 |
|
Actual shortage: | 243 (8%) | |
Anticipated shortage: | 15 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2766 (91%) | |
Discontinuation Reports |
356 |
|
To be discontinued: | 22 (6%) | |
Discontinued: | 334 (94%) | |
Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
32 (11%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-VALSARTAN/HCTZ | 12.5MG 80MG | TABLET | Resolved | 2017-03-10 | 2019-03-21 | 266 |
APO-VALSARTAN/HCTZ | 12.5MG 160MG | TABLET | Resolved | 2017-03-10 | 2019-03-21 | 263 |
APO-VERAP SR | 180MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2017-03-10 | 2019-12-04 | 260 |
APO-VERAP SR | 240MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2017-03-10 | 2019-12-04 | 255 |
APO-VORICONAZOLE | 200MG | TABLET | Resolved | 2017-03-10 | 2017-03-15 | 252 |
APO-ZOLPIDEM ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2017-03-10 | 2017-04-17 | 249 |
APO-ZOLPIDEM ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2017-03-10 | 2017-04-10 | 245 |
APO-CYCLOSPORINE ORAL SOLUTION | 100MG | SOLUTION | Resolved | 2017-03-10 | 2018-09-09 | 241 |
APO-CLINDAMYCIN | 300MG | CAPSULE | Resolved | 2017-03-10 | 2017-10-30 | 122 |
APO-CLINDAMYCIN | 150MG | CAPSULE | Resolved | 2017-03-10 | 2017-05-27 | 119 |
APO-CLARITHROMYCIN XL | 500MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-03-10 | 2017-05-05 | 116 |
APO-CITALOPRAM | 40MG | TABLET | Resolved | 2017-03-10 | 2017-04-07 | 113 |
APO-CIPROFLOX | 0.3% | SOLUTION | Resolved | 2017-03-10 | 2019-06-12 | 110 |
APO-CIPROFLOX | 500MG | TABLET | Resolved | 2017-03-10 | 2017-06-12 | 107 |
APO-CINACALCET | 30MG | TABLET | Resolved | 2017-03-10 | 2017-04-04 | 86 |
APO-CILAZAPRIL/HCTZ | 12.5MG 5MG | TABLET | Resolved | 2017-03-10 | 2017-04-04 | 83 |
APO-CILAZAPRIL | 1MG | TABLET | Resolved | 2017-03-10 | 2017-04-04 | 80 |
APO-CEFPROZIL | 500MG | TABLET | Resolved | 2017-03-10 | 2017-10-03 | 74 |
APO-CEFPROZIL | 250MG | TABLET | Resolved | 2017-03-10 | 2017-10-03 | 71 |
APO-BICALUTAMIDE | 50MG | TABLET | Resolved | 2017-03-10 | 2017-04-03 | 67 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-CEPHALEX | 250MG | TABLET | Discontinued | 2018-09-07 | 2019-02-21 | 60370 |
APO-CELECOXIB | 200MG | CAPSULE | Discontinued | 2018-09-07 | 2021-01-21 | 60366 |
APO-CELECOXIB | 100MG | CAPSULE | To be discontinued | 2018-09-07 | 2018-12-11 | 60363 |
APO-CAPTO TAB 6.25MG | 6.25MG | TABLET | Discontinued | 2018-09-07 | 2019-06-12 | 60339 |
APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60335 |
APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60331 |
APO-CANDESARTAN | 32MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60328 |
APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60325 |
APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60322 |
APO-CANDESARTAN | 4MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60319 |
APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60316 |
APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60313 |
APO-BROMAZEPAM | 6MG | TABLET | Discontinued | 2018-09-07 | 2018-10-19 | 60310 |
APO-BROMAZEPAM | 3MG | TABLET | Discontinued | 2018-09-07 | 2019-06-12 | 60307 |
APO-BROMAZEPAM | 1.5MG | TABLET | To be discontinued | 2018-09-07 | 2018-09-07 | 60304 |
APO-BRIMONIDINE | 0.2% | SOLUTION | Discontinued | 2018-09-07 | 2018-12-28 | 60301 |
APO-BRIMONIDINE | 0.2% | SOLUTION | To be discontinued | 2018-09-07 | 2018-09-07 | 60294 |
APO-BOSENTAN | 125.0MG | TABLET | Discontinued | 2018-09-07 | 2018-10-31 | 60291 |
APO-BISACODYL | 5MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-09-07 | 2018-09-15 | 60288 |
APO-ATORVASTATIN | 80MG | TABLET | Discontinued | 2018-09-07 | 2018-12-29 | 60285 |